Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
Business Model:
Revenue: $0
Employees: 11-50
Motus Therapeutics was acquired by
Allergan.
The acquisition happend on 2016-10-27.
Details of the transaction were not public
Address:
City: Boston
State: Massachusetts
Zip:
Country: United States
Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2012 | Venture Round | $9.5M | 7/2013 | Series B | $11M | 9/2015 | Grant | $1M | 9/2013 | Grant | 1 | $1.4M |
Michael J. Fox Foundation Michael J. Fox Foundation |
6/2012 | Series B | 4 | $25M |
Ipsen Third Rock Ventures New Enterprise Associates MPM Capital Third Rock Ventures New Enterprise Associates MPM Capital Ipsen |
3/2010 | Series A | 2 | $21M |
MPM Capital New Enterprise Associates MPM Capital New Enterprise Associates |
11/2012 | Series B | 5 | $8M |
Ipsen MPM Capital Third Rock Ventures Pfizer Venture Investments New Enterprise Associates Pfizer Venture Investments MPM Capital Ipsen Third Rock Ventures Pfizer Venture Investments New Enterprise Associates Pfizer Venture Investments |
9/2010 | Series A | 3 | $19M |
Third Rock Ventures New Enterprise Associates MPM Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|